Menu
Dividend AristocratsDividend KingsHigh YieldMonthly DividendDividend CalendarScreener

Pfizer Inc. Stock Price History

Pfizer Inc. EPS

EPSDividend / share
0.01.53.04.45.92007200920112013201520172019202120232025

Pfizer Inc. Dividend per Share

Forward Yield
6.56%
Annual Dividend
1.72 USD
Payout
131.30%
Frequency
Quarterly
Yrs of growth
15
CAGR 5Y
3.59%
Status
Dividend Grower
0.00.50.91.41.919871991199519992003200720112015201920232025

Pfizer Inc. Dividend Yield

Pfizer Inc. Payout Ratio

0%120%239%359%479%2007200920112013201520172019202120232025

Pfizer Inc. Dividend Growth

1Y CAGR
3Y CAGR
5Y CAGR
10Y CAGR
20Y CAGR
2.38%
2.44%
3.59%
5.49%
4.72%
Compound annual growth rate of dividend per share
Yield vs sector
6.56%
avg Healthcare: 2.97%
Next ex-dividend (est.)
2026-08-07
last: 2026-05-08
Ex-DateAmount
2026-05-080.43 USD
2026-01-230.43 USD
2025-11-070.43 USD
2025-07-250.43 USD
2025-05-090.43 USD
2025-01-240.43 USD
2024-11-080.42 USD
2024-07-260.42 USD

Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key therapeutic areas such as oncology, cardiology, immunology, and infectious diseases. Notable products in its portfolio include the pneumococcal vaccine Prevnar 13, cardiovascular treatments like Vyndaqel and Eliquis, and oncology drug Padcev. Pfizer Inc. serves markets in the United States and internationally, with significant contributions from emerging markets representing a substantial portion of international sales. The company addresses critical health needs through innovative medicines that treat chronic and acute conditions, playing a vital role in global healthcare delivery. Founded in 1849 and headquartered in New York, New York, Pfizer Inc. maintains a broad presence in the pharmaceutical industry, supporting patients, healthcare providers, and public health initiatives across diverse regions.